| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |